Last reviewed · How we verify

NCT04932993

Writing Down Goals

Withdrawn NA Last updated 31 July 2025
What this trial tests

NA trial testing Writing down goals in Musculoskeletal Diseases. Withdrawn.

Timeline
1 September 2025
Primary endpoint
1 October 2025
1 November 2025

Quick facts

Lead sponsorUniversity of Texas at Austin
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Start date1 September 2025
Primary completion1 October 2025
Estimated completion1 November 2025

Drugs / interventions tested

Conditions studied

Sponsor

University of Texas at Austin

Who can join

Adults 18 to 89, any sex, with Musculoskeletal Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The women's health IPU at UT Health Austin is happy with having patients write down their goals at their first visit and then tracking those. It would be interesting to study people seeking musculoskeletal specialty care to determine whether asking patients what result of their care would be rated a success helps direct the clinician-patient interaction in a more fruitful direction compared to the usual clinical interaction.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Musculoskeletal Diseases

Currently open trials in the same condition.

Other University of Texas at Austin trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04932993.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing